Which statement accurately describes data entry for compounded medications?

• A. Calculations May Be Different, Involving Factors or Conversions When Using APIs
• B. Directions Are Simple and Have Typical Measurements
• C. Compounded Prescriptions Use NDCs Which Are Not Used in Commercially Available Products
• D. None of the Above

Answer: (A)

Data entry for compounded medications often requires more complex math because each formulation is tailored, so you must account for potency, purity, and unit conversions. When active pharmaceutical ingredients are involved, the exact amount needed depends on the API’s actual strength (for example, a material that is only 98% pure means more raw API is required to reach the target dose). You also have to consider yield losses during preparation and convert between units (mg, g, mL, percent strength) to ensure the final label reflects the prescribed dose. This need to apply factors and perform conversions is why this description best fits data entry for compounded meds.

Directions and measurements aren’t always simple or standard in compounding, since recipes vary and may use nontraditional quantities. And compounded prescriptions generally don’t rely on standard NDCs, which identify manufactured products; some pharmacies may use internal identifiers, but that doesn’t make NDCs a defining feature of compounding. So the statement about calculations with APIs best describes the data-entry challenge.